, CR1*2 CR1*2, pp.10-15

, Notes: AD = Alzheimer's disease; CR1 = complement receptor 1, where numbers following asterisk denote an isoform; HH = individuals homozygous for the H allele (HindIII polymorphism)

, HL = individuals heterozygous for the HindIII polymorphism; LL = individuals homozygous for the L allele (HindIII polymorphism)

, QQ = individuals homozygous for the Q allele

, QH = individuals heterozygous for the Q981H polymorphism

H. ,

D. Harold, R. Abraham, P. Hollingworth, R. Sims, A. Gerrish et al., Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, Nature Genetics, vol.34, issue.10, pp.1088-1093, 2009.
DOI : 10.1212/WNL.56.1.127

M. L. Hamshere, J. S. Pahwa, and V. Moskvina, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease, Nat. Genet, vol.43, pp.429-435, 2011.

J. C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers et al., Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nature Genetics, vol.12, issue.10, pp.1094-1099, 2009.
DOI : 10.1042/bj2930027

J. C. Lambert, C. A. Ibrahim-verbaas, D. Harold, A. C. Naj, R. Sims et al., Bis, J.C

G. W. Beecham and B. Grenier-boley, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nat. Genet. Vardarajan, B.N.; Buros, J.; Gallins, P.J. J.D, vol.45, pp.1452-1458, 2013.

G. P. Jarvik and P. K. Crane, Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease, Nat. Genet, vol.43, pp.436-441, 2011.

S. Seshadri, A. L. Fitzpatrick, M. A. Ikram, A. L. Destefano, V. Gudnason et al., Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease, JAMA, vol.303, issue.18, pp.1832-1840, 2010.
DOI : 10.1001/jama.2010.574

S. L. Rosenthal and M. I. Kamboh, Late-Onset Alzheimer???s Disease Genes and the Potentially Implicated Pathways, Current Genetic Medicine Reports, vol.344, issue.2, pp.85-101
DOI : 10.1136/bmj.e1662

J. Rogers, R. Li, D. Mastroeni, A. Grover, B. Leonard et al., Peripheral clearance of amyloid ?? peptide by complement C3-dependent adherence to erythrocytes, Neurobiology of Aging, vol.27, issue.12, pp.1733-1739, 2006.
DOI : 10.1016/j.neurobiolaging.2005.09.043

J. A. Schifferli, Y. C. Ng, J. Estreicher, and M. J. Walport, The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement-and erythrocyte complement receptor 1-dependent mechanisms, J. Immunol, vol.140, pp.899-904, 1988.

F. G. Cosio, X. P. Shen, D. J. Birmingham, M. Van-aman, and L. A. Hebert, Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates, J. Immunol, vol.145, pp.4198-4206, 1990.

J. B. Cornacoff, L. A. Hebert, W. L. Smead, M. E. Vanaman, D. J. Birmingham et al., Primate erythrocyte-immune complex-clearing mechanism., Journal of Clinical Investigation, vol.71, issue.2, pp.236-247, 1983.
DOI : 10.1172/JCI110764

W. D. Brubaker, A. Crane, J. U. Johansson, K. Yen, K. Garfinkel et al., Peripheral complement interactions with amyloid ?? peptide: Erythrocyte clearance mechanisms, Alzheimer's & Dementia, vol.13, issue.12, pp.1397-1409, 2017.
DOI : 10.1016/j.jalz.2017.03.010

J. U. Johansson, W. D. Brubaker, and H. Javitz, J

D. Mastroeni and A. J. Tenner, Peripheral complement interactions with amyloid ? peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1, Alzheimers Dement, 2018.

M. Krych-goldberg and J. P. Atkinson, Structure-function relationships of complement receptor type 1, Immunological Reviews, vol.180, issue.1, pp.112-122, 2001.
DOI : 10.1034/j.1600-065X.2001.1800110.x

D. J. Birmingham, W. Chen, G. Liang, H. C. Schmitt, K. Gavit et al., A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b, Immunology, vol.10, issue.4, pp.531-538, 2003.
DOI : 10.1046/j.1365-2249.1999.00940.x

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2567.2003.01579.x/pdf

D. Liu and Z. Niu, The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35). Immunopharm. Immunot, pp.524-535, 2009.
DOI : 10.1080/08923970902845768

J. H. Cohen, H. U. Lutz, J. L. Pennaforte, A. Bouchard, and M. D. Kazatchkine, Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE), Clinical & Experimental Immunology, vol.29, issue.3, pp.422-428, 1992.
DOI : 10.1042/bj2350815

P. Cornillet, F. Philbert, M. D. Kazatchkine, and J. H. Cohen, Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion, Journal of Immunological Methods, vol.136, issue.2, pp.193-197, 1991.
DOI : 10.1016/0022-1759(91)90006-2

J. R. He, J. Xi, Z. F. Ren, H. Qin, Y. Zhang et al., Complement Receptor 1 Expression in Peripheral Blood Mononuclear Cells and the Association with Clinicopathological Features And Prognosis of Nasopharyngeal Carcinoma, Asian Pacific Journal of Cancer Prevention, vol.13, issue.12, pp.6527-6531, 2012.
DOI : 10.7314/APJCP.2012.13.12.6527

R. Mahmoudi, A. Kisserli, J. L. Novella, B. Donvito, M. Drame et al., Alzheimer's disease is associated with low density of the long CR1 isoform, Neurobiology of Aging, vol.36, issue.4, pp.1766-1771, 2015.
DOI : 10.1016/j.neurobiolaging.2015.01.006

J. G. Wilson, E. E. Murphy, W. W. Wong, L. B. Klickstein, J. H. Weis et al., Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes, Journal of Experimental Medicine, vol.164, issue.1, pp.50-59, 1986.
DOI : 10.1084/jem.164.1.50

W. W. Wong, J. M. Cahill, M. D. Rosen, C. A. Kennedy, E. T. Bonaccio et al., Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele, Journal of Experimental Medicine, vol.169, issue.3, pp.847-863, 1989.
DOI : 10.1084/jem.169.3.847

L. Xiang, J. R. Rundles, D. R. Hamilton, and J. G. Wilson, Quantitative alleles of CR1: Coding sequence analysis and comparison of haplotypes in two ethnic groups, J. Immunol, vol.163, pp.4939-4945, 1999.

A. H. Herrera, L. Xiang, S. G. Martin, J. Lewis, and J. G. Wilson, Analysis of Complement Receptor Type 1 (CR1) Expression on Erythrocytes and of CR1 Allelic Markers in Caucasian and African American Populations, Clinical Immunology and Immunopathology, vol.87, issue.2, pp.176-183, 1998.
DOI : 10.1006/clin.1998.4529

B. N. Pham, A. Kisserli, B. Donvito, V. Duret, B. Reveil et al., Analysis of complement receptor Type 1 expression on red blood cells in negative phenotypes of the Knops blood group system, according to CR1 gene allotype polymorphisms, Transfusion, vol.64, issue.7, pp.1435-1443, 2010.
DOI : 10.1111/j.1365-2249.1992.tb03013.x

S. H. Yoon and D. Fearon, Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma, J. Immunol, vol.134, pp.3332-3338, 1985.

M. R. Ehlers and J. Riordan, Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins, Biochemistry, vol.30, issue.42, pp.10065-10074, 1991.
DOI : 10.1021/bi00106a001

X. Dervillez, S. Oudin, M. T. Libyh, T. Tabary, B. Reveil et al., Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35) : vesiculation and/or proteolysis?, Immunopharmacology, vol.38, issue.1-2, pp.129-140, 1997.
DOI : 10.1016/S0162-3109(97)00066-0

I. Hamer, J. P. Paccaud, D. Belin, C. Maeder, and J. L. Carpentier, Soluble form of complement C3b/C4b receptor (CR1) results from a proteolytic cleavage in the C-terminal region of CR1 transmembrane domain, Biochemical Journal, vol.329, issue.1, pp.183-190, 1998.
DOI : 10.1042/bj3290183

M. Jacquet, M. Lacroix, S. Ancelet, E. Gout, C. Gaboriaud et al., Deciphering Complement Receptor Type 1 Interactions with Recognition Proteins of the Lectin Complement Pathway, The Journal of Immunology, vol.190, issue.7, pp.3721-3731, 2013.
DOI : 10.4049/jimmunol.1202451

URL : https://hal.archives-ouvertes.fr/hal-01322429

A. Kubiak-wlekly, A. Perkowska-ptasinska, P. Olejniczak, A. Rochowiak, E. Kaczmarek et al., The comparison of the podocyte expression of synaptopodin, CR1 and neprilysin in human glomerulonephritis: Could the expression of CR1 be clinically relevant?, Int. J. Biomed. Sci, vol.5, pp.28-36, 2009.

M. I. Fonseca, S. Chu, A. L. Pierce, W. D. Brubaker, R. E. Hauhart et al.,

J. P. Atkinson and A. J. Tenner, Analysis of the putative role of CR1 in Alzheimer's disease: Genetic association, expression and function, PLoS ONE, vol.2016, issue.11

M. Malik, I. Parikh, J. B. Vasquez, C. Smith, L. Tai et al., Genetics ignite focus on microglial inflammation in Alzheimer???s disease, Molecular Neurodegeneration, vol.6, issue.12, p.52, 2015.
DOI : 10.12703/P6-13

B. P. Morgan, Complement in the pathogenesis of Alzheimer???s disease, Seminars in Immunopathology, vol.541, issue.7638, pp.113-124, 2018.
DOI : 10.1038/nature21029

N. Brouwers, C. Van-cauwenberghe, S. Engelborghs, J. C. Lambert, K. Bettens et al., Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites, Molecular Psychiatry, vol.28, issue.2, pp.223-233, 2012.
DOI : 10.1523/JNEUROSCI.0829-08.2008

L. N. Hazrati, C. Van-cauwenberghe, P. L. Brooks, N. Brouwers, M. Ghani et al., Van Broeckhoven, C.; et al. Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism, Neurobiol. Aging, vol.33, pp.2949-2954, 2012.

E. Kucukkilic, K. Brookes, I. Barber, T. Guetta-baranes, K. Morgan et al., Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer???s disease, Human Genetics, vol.169, issue.2235, pp.305-314, 2018.
DOI : 10.1098/rsif.2017.0057

M. S. Currie, M. Vala, D. S. Pisetsky, C. S. Greenberg, J. Crawford et al., Correlation between erythrocyte CR1 reduction and other blood proteinase markers in patients with malignant and inflammatory disorders, Blood, vol.75, pp.1699-1704, 1990.

G. D. Ross, W. J. Yount, M. J. Walport, J. B. Winfield, C. J. Parker et al., Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation, J. Immunol, vol.135, pp.2005-2014, 1985.

M. Pascual, H. U. Lutz, G. Steiger, P. Stammler, and J. A. Schifferli, Release of vesicles enriched in complement receptor 1 from human erythrocytes, J. Immunol, vol.151, pp.397-404, 1993.

R. Mayeux and Y. Stern, Epidemiology of Alzheimer disease. CSH Perspect, Med. 2012

B. N. Thomas, B. Donvito, I. Cockburn, T. Fandeur, J. A. Rowe et al., A complement receptor-1 polymorphism with high frequency in malaria endemic regions of Asia but not Africa, Genes & Immunity, vol.91, issue.Suppl 1???2, pp.31-36, 2005.
DOI : 10.1073/pnas.91.7.2415

. American-psychiatric-association, Diagnostic and Statistical Manual of Mental Disorders, 1994.
DOI : 10.1176/appi.books.9780890425596

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, pp.939-944, 1984.
DOI : 10.1212/WNL.34.7.939

J. Cook, E. Fischer, C. Boucheix, M. Mirsrahi, M. H. Jouvin et al., Mouse monoclonal antibodies to the human C3b receptor, Mouse monoclonal antibodies to the human C3b receptor, pp.531-539, 1985.
DOI : 10.1016/0161-5890(85)90176-2

E. Kiss, I. Csipo, J. H. Cohen, B. Reveil, M. Kavai et al., CR1 Density Polymorphism and Expression on Erythrocytes of Patients with Systemic Lupus Erythematosus, Autoimmunity, vol.35, issue.1, pp.53-58, 1996.
DOI : 10.1038/ki.1987.81

A. Kisserli, T. Tabary, J. H. Cohen, V. Duret, and R. Mahmoudi, High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment, Journal of Visualized Experiments, issue.125, pp.125-56012, 2017.
DOI : 10.3791/56012

A. Crane, W. D. Brubaker, J. U. Johansson, and A. Trigunaite, Ceballos, J.; Bradt, B C

T. L. Wallace, A. J. Tenner, and J. Rogers, Peripheral complement interactions with amyloid ? peptide in Alzheimer's disease: 2. Relationship to amyloid ? immunotherapy, Alzheimers Dement, vol.14, pp.243-252, 2018.